Literature DB >> 1783899

Electrophoretic karyotypes of clinically isolated yeasts of Candida albicans and C. glabrata.

K Asakura1, S Iwaguchi, M Homma, T Sukai, K Higashide, K Tanaka.   

Abstract

One-hundred-and-four isolates of yeast were collected from the vaginas of 97 outpatients. The isolates were identified by their characteristics in a carbohydrate assimilation test, a serological test and from their morphology. Candida albicans and Candida glabrata were the major isolates (75% and 20%, respectively). The karyotypes of the isolates were analysed by pulsed-field gel electrophoresis and almost all the karyotypes were distinguishable from one another when the band mobilities were carefully compared. Characteristics and karyotypes were not directly correlated, but seven C. albicans isolates (from six patients) had a common atypical karyotype and shared the same phenotype. These isolates are inferred to be generated by a wide genomic reorganization and mutation and the phenotypic changes may be advantageous for survival. The karyotypes of the isolates recovered from individual patients after intervals of 1-6 months were all identical except for one or two highly variable bands which were identified with an rDNA probe. This suggests that the variable bands are too variable to be useful for distinguishing strains, but from the patterns of the identical bands (i.e. except for the variable bands) we concluded that strains from individual patients do not change, at least over short periods. This, coupled with the extensive inter-isolate variability in karyotype, will be useful for Candida source determination and epidemiological studies.

Entities:  

Mesh:

Year:  1991        PMID: 1783899     DOI: 10.1099/00221287-137-11-2531

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  30 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans.

Authors:  C Pujol; S Joly; S R Lockhart; S Noel; M Tibayrenc; D R Soll
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  Electrophoretic karyotypes of clinical isolates of Coccidioides immitis.

Authors:  S Pan; G T Cole
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

4.  Effect of the major repeat sequence on chromosome loss in Candida albicans.

Authors:  Paul R Lephart; Hiroji Chibana; Paul T Magee
Journal:  Eukaryot Cell       Date:  2005-04

5.  Techniques for investigation of an apparent outbreak of infections with Candida glabrata.

Authors:  S Arif; T Barkham; E G Power; S A Howell
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

6.  Molecular epidemiology of Candida isolates from AIDS patients showing different fluconazole resistance profiles.

Authors:  A Lischewski; M Ruhnke; I Tennagen; G Schönian; J Morschhäuser; J Hacker
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Karyotyping of Cryptococcus neoformans as an epidemiological tool.

Authors:  J R Perfect; N Ketabchi; G M Cox; C W Ingram; C L Beiser
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

8.  Induced chromosome rearrangements and morphologic variation in Candida albicans.

Authors:  R C Barton; S Scherer
Journal:  J Bacteriol       Date:  1994-02       Impact factor: 3.490

9.  Molecular epidemiology of Candida albicans and its closely related yeasts Candida dubliniensis and Candida africana.

Authors:  Orazio Romeo; Giuseppe Criseo
Journal:  J Clin Microbiol       Date:  2008-11-05       Impact factor: 5.948

10.  Low dosage of histone H4 leads to growth defects and morphological changes in Candida albicans.

Authors:  Lucia F Zacchi; Anna M Selmecki; Judith Berman; Dana A Davis
Journal:  PLoS One       Date:  2010-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.